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Abstract 
The Australian Home Medicines Review (HMR) Program, aimed at reducing the number of 
medication-related problems and hospital admissions, has not been used to the extent projected and 
is little known among eligible consumers. 
PURPOSE: This paper investigates the problems patients and caregivers have with using medicines 
appropriately, their desire for assistance with managing medications and their self-perceived need for 
a Home Medicines Review. 
DESIGN: A qualitative research study was conducted with 8 semi-structured focus groups including a 
total of 50 HMR-eligible patients and caregivers. Participants who were purposively sampled 
represented older males, older females, younger chronically ill patients, patients from Chinese and 
Arabic backgrounds and the general HMR target group.  
FINDINGS: According to the types of medicine problems encountered by participants, their level of 
medicine understanding and their desire for assistance with using medicines, four distinct patient types 
are identified and explicated: the heedless patient, the aware patient, the scrupulous patient and the 
self-sufficient patient.  
PRACTICAL IMPLICATIONS: The uptake of the HMR service can be effectively increased by direct-
to-consumer HMR promotion that is tailored to the behaviors, needs and desires of eligible patients 
and caregivers. The proposed segmentation model of HMR-eligible consumers addresses these 
differences and can be used to inform health policy makers regarding a more effective promotion of 
the HMR service. 
ORIGINALITY: This is the first study to investigate how the HMR-uptake could be increased from the 
perspective of eligible patients and their caregivers. 
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INTRODUCTION 
There is increasing evidence that a significant number of patients and caregivers are using medicines 
inappropriately (Barber et al., 2004, Batty et al., 2003), involving the risk of hospital admission. A 
variety of studies have shown that up to 2.5% of emergency hospital admissions are due to potentially 
preventable medication-related incidents (Leendertse et al., 2008, Sikdar et al., 2010). Lack of 
knowledge regarding medicines has been found to cause widespread concern and anxiety among 
patients and caregivers, increasing the likelihood of patients and caregivers altering or ceasing the 
prescribed medicines therapy without discussing this with their health care providers (Pit et al., 2008).  
The Australian Home Medicine Review (HMR) program was introduced in October 2001 with the aim 
to assist patients living at home to maximize the benefits of their medicines and prevent medication 
related problems
[1]
. An HMR is a free consumer service provided collaboratively by doctors and 
pharmacists specifically for patients who take multiple medicines each day, have recently spent time in 
hospital, see multiple general practitioners (GPs) and/or specialist doctors, or are concerned, confused 
or uncertain about their medicines. The service is initiated by the patient’s usual GP who generates a 
referral to the patient’s local pharmacist. The latter organizes a specially trained pharmacist to conduct 
an interview with the patient, preferably in the patient’s home. During the approximately one-hour long 
visit, the patients’ medicines are discussed and inspected. The pharmacist summarizes his/her 
findings in a report to the GP, who then discusses the pharmacist’s recommendations with the patient 
and may make appropriate changes to their medication regime. The involvement of a caregiver in this 
process is optional and depends on the individual relationship between patient and caregiver. 
To date, the total number of HMRs performed has remained well below the number projected by the 
Australian government
[2]
. One possible reason for this slow uptake could lie in the limited direct-to-
consumer promotion of the service and, related to that, the extremely low HMR awareness levels 
among eligible patients and their caregivers (Authors, 2009). Whilst numerous studies have 
investigated the GPs’ and pharmacists’ attitudes towards the HMR program and identified a variety of 
barriers to the uptake of the HMR program from the provider’s perspective (Bennett et al., 2000, 
Benrimoj et al., 2004, Campbell Research & Consulting, 2008, Schwartzkoff, 2005), little research has 
focused on examining the patient/caregiver perspective. Chen and Larkin (2002) have reported that 
the HMR increases the patient’s understanding of their medicines and improves the relationship 
between patient and community pharmacist. Similarly, Schwartzkoff (2005) and Campbell Research & 
Consulting (2008) have concluded that patients are generally well-satisfied with the HMR service. 
Our study aims to extend the existing knowledge regarding the consumer perspectives on the HMR 
program with a view to elicit the effectiveness of a potential direct-to-consumer promotion of the HMR 
and to provide first insights into the possible content and delivery formats of such promotional 
messages. Specifically, we explored the attitudinal and behavioral patterns of HMR-eligible patients
[3]
 
and their caregivers with regard to the use of medicines and investigated the perceptions of these 
consumer groups concerning the benefits and barriers of the HMR program as well as their level of 
desire to have this service. 
  
METHODS 
Participants 
Eight semi-structured focus groups were conducted with a total of 50 participants, 38 of whom were 
HMR-eligible patients who have never received an HMR and 12 caregivers of such patients. The 8 
groups consisted of two groups of consumers from the general HMR target group, one group each 
with older men and older women (over 74 years old), two groups with younger chronically ill patients 
(under 65 years old) and one group each with patients from Chinese and Arabic backgrounds. The 
Chinese and Arabic participants were included if they spoke their native language at home and had 
limited English skills. Groups were held in both city and regional areas, across a range of Australian 
states. An overview of the focus groups and participant types is given in table 1. 
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Table 1: Focus Group and Participants’ Characteristics 
Consumer 
segment 
Definition of consumer 
segment 
Number of 
focus groups 
Number of participants 
per focus group 
Patients Caregivers 
General HMR 
target population  
Patients and carers who are not 
included in any of the specific 
segments (below) 
2 
Group A:10 
Group B: 7 
Group A: 1 
Group B: 4 
Older men Male patients 75 years and older 1 5 1 
Older women Female patients 75 years and 
older 
1 4 1 
Younger 
chronically ill 
patients 
Patients under the age of 65, 
who have a chronic illness 
and/or other serious health 
problems 
2 
Group A: 3 
Group B: 2 
Group A: 0 
Group B: 1 
Chinese patients Patients from Chinese 
(Mandarin) ethnic and language 
background 
1 4 2 
Arabic patients Patients from Arabic ethnic and 
language background 
1 3 2 
Total  8 38 12 
 
Participants were identified by (bi-lingual) community pharmacists who provided suitable and 
interested candidates with a briefing of the study’s aims and an information sheet, and invited them to 
participate in the study. The pharmacists also collected signed ‘consent to be contacted’ forms from 
potential study participants, which were passed on to the researchers. Those patients and caregivers 
who had agreed to participate were contacted by a research assistant and, after confirmation of their 
HMR eligibility, invited to a one-hour focus group session that was organized in the 
patients’/caregivers’ local area. A signed consent form was obtained at the beginning of each focus 
group, which included an approval to be tape recorded and an assurance of anonymity and 
confidentiality of data. 
Ethics approval had been obtained from the University Ethics Committee prior to the commencement 
of the research. 
 
Data collection 
Each focus group was facilitated by HMR-experienced pharmacist-researchers and lasted between 40 
and 90 minutes. Language problems with the Chinese and Arabic participants were overcome by 
conducting the two ethnic focus groups in the community languages, Mandarin and Arabic. Each of 
these groups was moderated by a health care interpreter, a bi-lingual HMR-experienced pharmacist 
and one member of the research team. The interpreters and the bi-lingual pharmacists were briefed 
about the purpose and aims of the study and familiarized with the group discussion guide prior to the 
commencement of the focus group sessions. 
A prepared interview discussion guide ensured consistency of the topics discussed across the focus 
groups while also giving individual groups the space to raise and discuss issues that were of particular 
importance to them. In the first part of each session, participants were invited to discuss what kind of 
medicine problems they tended to experience and how they managed these. The relationships of the 
participants with their pharmacists and GPs were then explored. Respondents were asked if they had 
been aware of the HMR before being invited to attend the focus group and what they thought this 
service would entail. In the second part of the focus group meetings, the HMR program was explained 
and participants were asked about their perceptions of this service and whether or under which 
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circumstances they would consider using it. Finally, it was investigated if participants would ask their 
GP for an HMR referral and whether they would recommend the HMR program to friends and family. 
It has been shown that focus groups offer researchers a powerful investigative potential especially in 
the areas of consumer behavior, patient-provider collaboration, health literacy research, and disease 
and medication management (Huston and Hobson, 2008). The mostly open-ended questions and the 
group discussion format facilitated a detailed exploration of the patients’ and caregivers’ beliefs, views 
and behaviors, stimulated the exchange of ideas and assisted participants to refine their individual 
viewpoints by comparing them to other participants’ ideas and perceptions. The focus groups further 
provided a protecting place that gave participants a sense of trust and community, which made them 
feel comfortable in expressing their views (Huston and Hobson, 2008, Kitzinger, 1995). Many of the 
participants were extremely grateful for the opportunity to talk about their medicines and be listened to 
by knowledgeable health professionals (i.e. the researchers) who genuinely cared. 
 
Data analysis 
All focus groups sessions were audio recorded and transcribed verbatim. The Chinese and Arabic 
session transcripts were translated into English using professional translators. The translations were 
checked for accuracy and any meaning ambiguities by the bi-lingual pharmacists who had co-
facilitated the sessions.  
Immediately after the conclusion of each focus group session, each session was debriefed by the 
research team members (for the two ethnic sessions, this included the interpreters and bi-lingual 
pharmacists), impressions of agreement and controversy discussed and the findings summarized in 
an abridged report. After reading and re-reading the transcripts, listening to the session tapes and 
studying the session notes, thematic analysis was used to analyse the data involving a three-step 
process (Liamputtong, 2009): First, codes were generated with the assistance of NVivo 8, and collated 
into tentative themes, which were checked  back across the entire data set. Second, the codes were 
connected into categories and sub-categories and relationships established between categories to find 
themes. Third, the themes were mapped, defined and names for each theme generated. 
Discrepancies between researchers were resolved in team discussions involving the chief-investigator 
and the two co-researchers (Barbour, 2001). 
The four patient segments, which are described and discussed in the following sections, emerged as 
an outcome of this rigorous analytic process. 
 
 
RESULTS 
From the participants’ accounts, numerous problems with the correct use of medicines emerged. 
These included a lack of information, worry about side effects and interactions, cognitive and/or 
physical impairments, confusion about generic drugs, medication non-adherence and language 
problems, as detailed following.   
Lack of information: Participants reported that they did not have sufficient information concerning 
their medications and that Consumer Medicines Information (CMI) leaflets did not mediate this lack of 
information but rather induced more worry and anxiety. Respondents appreciated pharmacists who 
took the time to explain the prescribed medicines and were available to answer questions. Conversely, 
disappointment was expressed with pharmacists who were seen as ‘too busy’ to approach for advice 
when the patient/caregiver needed it. Participants were also dissatisfied with the perceived low level of 
willingness of their GPs to explain the risks and benefits of the prescribed medications. 
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Side effects and interactions: Many participants reported having experienced side effects from their 
medicines and finding the CMIs too detailed and too complicated to read and understand. Some 
respondents speculated that their GPs would experiment with dosages and medicines in an attempt to 
determine which medication caused which side effect or interaction.  
Cognitive and physical problems: Problems relating to the cognitive and physical condition of 
patients emerged as some participants acknowledged that they occasionally forgot to take the 
prescribed medication, which in turn caused them to worry about side effects when they realised that 
they had missed doses. This problem was reported more often by male participants and by those who 
are more elderly. 
Deliberate non-adherence: A tendency to “self-medicate” was reported by participants who 
perceived the medication regimen that their GP had chosen as ‘over prescribed’. This perception led 
some patients to stop taking or reduce their medicines for varying periods of time. The deliberately 
non-adherent participants saw themselves as being caught between the positive and the negative 
effects of medicines and between their doctor’s and their own medication decisions. The reluctance to 
discuss non-adherence with the GP was increased by the participants’ realisation that they were 
challenging their GPs’ authority. 
Generic brand confusion: Several participants reported that they relied on packaging recognition of 
medicines, which gave them confidence of its content. Generic brands were for that reason looked 
upon unfavourably and, if possible, avoided. Other respondents judged the generic brands as less 
effective than the original brands because of their lower price. 
Language barrier: Low English language skills were raised as a barrier to the correct medication 
usage by both the Chinese and the Arabic speaking participants. Whilst most ethnic participants 
visited GPs who were from the same ethnic and language background, they reported having 
difficulties finding bilingual community pharmacists and, hence, understanding the medication advice 
given by English-only speaking pharmacists at the time of dispensing.   
In summary, the focus group data showed that many participants had doubts and hesitations in 
relation to the appropriate use of their medicines, which triggered different reactions, ranging from a 
sense of powerlessness to anxiety or deliberate non-adherence. Two variables were identified as 
being fundamental to the participants’ perceptions: the level of understanding that participants had 
regarding medicines and their desire for assistance with the use of medicines. Using these variables, 
patients
[4]
 can be grouped into four distinct segments; the heedless, the aware, the scrupulous and the 
self-sufficient patient (refer to table 2). 
 The heedless patient displays a poor understanding of the risks concerning the 
mismanagement of medicines, but does not want to be helped in managing their 
medications. 
 The aware patient is conscious of their poor understanding and would appreciate and 
actively seeks assistance when managing their medications. 
 The scrupulous patient understands the detail and the importance of their medicine 
regimen and is aware of the risks related to medication mismanagement. For this reason, 
this patient pays special attention to how they use their medicines and regularly asks for 
assistance and advice.  
 The self-sufficient patient understands the details and importance of their medicine 
regimen but does not desire assistance with it.  
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Table 2: Patient Segmentation Matrix 
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The heedless  
patient 
The aware  
patient 
C
le
a
r 
The self-sufficient  
patient 
The scrupulous  
patient 
    
The relationship between the medicine problems reported above and these four patient categories can 
be explained as follows. The heedless patient mistrusts medicines. S/he worries about side effects 
and medicine interactions and believes that it is possible to reduce these risks through reducing the 
dose or ceasing to take the prescribed medicines. This patient is at risk of medication misadventure 
caused by non-compliance and often the fact that the non-compliance is hidden from the GP. The 
heedless patient is suitable for HMRs as an HMR-pharmacist would be able to help the patient to 
rebuild trust in, and a better understanding of their medicines. 
Whilst the aware patient has good intentions regarding adhering to the prescribed medication regimen, 
s/he finds it difficult to remember medicine names and doses and is worried about problems with 
medicine recognition. S/he is easily confused by changes in product packaging or by generic brand 
substitution. His/her confusion may be linked to the difficulty of speaking and/or understanding 
English. The anxiety felt by the aware patient is not so much related to side effects or medicine 
interactions as to remembering and understanding to take the medications in the correct dose. This 
would represent a key target group for HMR marketing. 
The scrupulous patient is worried about medicine interactions and side effects and confused about 
medicine information. S/he proactively seeks information from a variety of sources and is desirous of 
in-depth advice from a health care professional who can satisfy their information need and sort out 
his/her confusion caused by accessing a multitude of information sources. This patient is aware of new 
products and generics. Patients with language difficulties can fall into this category. Such patients 
require only awareness of the HMR service to be eager to participate. 
The self-sufficient patient is independently managing his/her medication. In general, s/he is fluent in 
English, feels well-informed about his/her medicines, and does not present any cognitive or physical 
impairment regarding medication recognition and use. This patient is of significant lower risk of 
medication misadventure than patients belonging to the other three categories and would not be a 
primary target for HMR marketing strategies.  
For an overview of the patient categories and their characteristics refer to table 3. 
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Table 3: Patient Segments, Medication Management Problems and Self-Perceived HMR Need 
Patient category Problems with appropriate use of 
medicines  
Self-perceived 
HMR need  
The heedless patient  Fear of side effects and medicine 
interactions 
 Deliberate non-adherence 
Yes 
The aware patient  Cognitive and/or physical 
impairments 
 Medicine recognition problems 
 Language barriers 
Yes 
The scrupulous patient  Information seeking 
 Information confusion 
 Worry of medicine interactions and 
side effects 
Yes 
The self-sufficient patient None perceived No 
 
DISCUSSION 
Inappropriate use of medicines is a common cause of hospitalisation, particularly among elderly 
multiple medicine users (Leendertse et al., 2008, Sikdar et al., 2010). To reduce medicine-related 
problems and the number of preventable hospital admissions, the Australian Government introduced 
the HMR program, which has – in its first decade of existence - not been used to the projected 
extent
[5]
. This study has explored the medicine-related beliefs, behaviors and coping strategies of 
HMR-eligible patients and their caregivers, and on this basis, a patient segmentation model has been 
developed that can be used to inform health policy makers regarding a more effective direct-to-
consumer promotion of the HMR service by targeting different patient types with different promotional 
strategies. Any initiative that aims to encourage a patient’s appropriate use of medicines and full 
cooperation with health care providers will only be successful to the degree that the patient’s needs, 
beliefs, behaviors and motivations as well as their physical and cognitive limitations are taken into 
account. This study has identified major medicine problems encountered by patients and categorized 
patients accordingly.  
Segmentation is a valuable marketing tool which allows a large heterogeneous group of consumers to 
be broken down into smaller homogenous groups. Within each group, or segment, every individual 
can be expected to react to a particular marketing offer in a similar manner. Thus, marketing strategies 
can be designed to address the needs of each segment which are more likely to meet the needs of 
that particular group of individuals. Although the actual HMR service will remain unchanged across all 
segments and the HMR is provided at no charge to all consumers, the promotional strategy can, and 
indeed should, vary between the different segments. In addition, a segmentation strategy is also 
valuable in that it allows prioritisation of the different segments to be conducted, when there are 
insufficient resources available to provide the service simultaneously to all segments. 
Three of the four patient categories could be targeted in a promotional campaign for HMRs, each with 
a different promotional strategy to increase the uptake. The fourth category, the self-sufficient patient, 
is unlikely to need an HMR to the same extent as the other three groups and therefore would not be 
considered a priority target group due to his/her strong sense of self-reliance and cooperation with 
their health care providers. The heedless patient could be targeted with a campaign that compares 
and contrasts the risks relating to medication non-adherence versus the risks of medication 
interactions and side effects. The aware patient could be reached with a campaign that includes 
addressing caregivers encouraging them to play an active and informed role in the management of 
their care recipients’ medicines. As the aware patient is cognizant of the fact that s/he needs help with 
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their medicine use, a suitable marketing strategy for this patient category will also include reminding 
the aware patient of the professional assistance that a pharmacist can provide to him/her through the 
HMR. The scrupulous patient is probably the least complex category to target. S/he is proactive in 
searching for information concerning his/her health and is likely to respond readily to any awareness 
campaign of the HMR service. A brochure outlining the purpose and aim of the HMR program may be 
the only trigger s/he needs to ask their GP or pharmacist for more information about the service. 
This study demonstrates that the uptake of the HMR program can be effectively increased by direct-to-
consumer communication strategies that are tailored to the needs, beliefs, behaviors, motivations and 
limitations of specific patient categories. It must however be ensured that any such campaigns target 
HMR-eligible patients only, specifically those who are at highest risk of medication misadventure, and 
that the supply of available HMR-accredited pharmacists be built up to meet an increased demand. 
 
Study limitations/further research 
The study is limited by the relatively small sample size (50 patients) and did not include patients who 
were unable (or unwilling) to attend a focus group, e.g. due to physical inability to leave their homes. 
Whilst the study included caregivers of such house-bound patients, the caregiver perspective is likely 
to differ from the patient perspective. Home-based interviews with physically impaired patients would 
therefore be a beneficial addition to this study. Further research could also include patients and 
caregivers with different lifestyles, such as remote and rural patients/caregivers and Aboriginal and 
Torres Strait Islanders, as well as patients who have already had an HMR or those who have refused 
to receive this service, to test the fit and examine the generalizability of the proposed patient 
categories. Another option would be to specifically investigate the perspectives of those ‘high-risk’ 
patients who have experienced preventable medicine-related emergency hospital admissions.  
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[1]
 Commonwealth Department of Health and Aging, “Home Medicine Review: helping your patients/caregivers 
manage their medicine at home”, www.health.gov.au , accessed March 2009 
[2]
 Pharmacy Guild of Australia, HMR Statistics 2009, accessed via http://www.guild.org.au/mmr 
[3]
 The Australian Government has devised the following non-exclusive list of risk factors that are used to identify 
HMR-eligibility:  “Examples of risk factors include patients: 
 currently taking five or more regular medications 
 taking more than 12 doses of medication per day 
 with significant changes to their medication regimen in the last three months, including recent 
discharge from hospital 
 taking medication with a narrow therapeutic index or required therapeutic monitoring 
 with symptoms suggestive of an adverse drug reaction 
 having difficulty managing their own medicines because of literacy or language difficulties, 
impaired sight 
 attending a number of different doctors, both general practitioners and specialists 
The HMR service is not available to in-patients of a hospital, day hospital facility or care recipients in 
residential aged-care facilities.” (Source: Medicare Australia, http://www9.health.gov.au/mbs/) 
[4]
 In the following discussion the term ‘patient’ includes caregivers to the extent to which the latter are 
involved in making medicine decisions for the person they care for. 
[5]
 Pharmacy Guild of Australia, HMR Statistics 2009, accessed via http://www.guild.org.au/mmr  
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